Skip to main content
SpringerLink
Log in

Mortality risk: sedative drugs and opioid agonist treatment

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. zaleplone, zolpidem, zopiclone

Reference

  • MacLeod J, et al. Prescription of benzodiazepines, z-drugs, and gabapentinoids and mortality risk in people receiving opioid agonist treatment: Observational study based on the UK Clinical Practice Research Datalink and Office for National Statistics death records. PLOS Medicine : 26 Nov 2019. Available from: URL: https://doi.org/10.1371/journal.pmed.1002965

    Article  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mortality risk: sedative drugs and opioid agonist treatment. Reactions Weekly 1784, 10 (2019). https://doi.org/10.1007/s40278-019-72729-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-019-72729-3

Search

Navigation